8 min. read

2021 Prescription DTx report. Headspace’s 2020 prediction.

Welcome back to E&O Fridays, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health.

 E&O Fridays.

Here's what's happening this week in the world of pharma digital products and FDA-regulated digital health:

  • The big digital health pharma deal was AliveCor's tie-up with AstraZeneca: The two will "research new disease

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Recent Articles